| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 9 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | Israel | 3 | |
| #4 | Hong Kong | 2 | |
| #5 | Japan | 2 | |
| #6 | Republic of Korea | 2 | |
| #7 | New Zealand | 2 | |
| #8 | Taiwan | 2 | |
| #9 | Canada | 1 | |
| #10 | China | 1 | |
| #11 | Mexico | 1 | |
| #12 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Measurement | |
| #4 | Control | |
| #5 | Medical technology | |
| #6 | Biotechnology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Breitenbucher James | 10 |
| #2 | Gomez Laurent | 8 |
| #3 | Kaplan Alan | 8 |
| #4 | Vickers Troy | 8 |
| #5 | Lemus Robert | 7 |
| #6 | Marrone Tami Jo | 6 |
| #7 | Santora Vincent | 6 |
| #8 | Basinger Jillian | 6 |
| #9 | Chen Mi | 5 |
| #10 | Renick Joel | 4 |
| Publication | Filing date | Title |
|---|---|---|
| JP2017128603A | Substituted pyridineazolopyrimidine-5-(6h)-one compound | |
| TW201619162A | Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as pde2 inhibitors | |
| TW201625523A | Substituted azetidinyl compounds as glyt1 inhibitors | |
| EP3134406A1 | Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2h-pyrazolo [4,3-c]pyridine compounds as glyt1 inhibitors |